Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.

OBJECTIVE Raised plasma levels of procalcitonin (proCT) represent an early marker for septicaemia. They are related to disease severity and inversely to outcome and response to treatment. ProCT is presumably synthesised in tIssues other than the thyroid C-cells which are the source of calcitonin (CT) in normal physiology. This study compares proCT and its cleavage products in the serum of patients with septicaemia with those in medullary thyroid carcinoma (MTC). METHODS Immunoreactive proCT and its cleavage products were extracted from the serum of patients with septicaemia or MTC using octadecylsilyl silica columns and characterised by reversed phase HPLC and Western blot analysis. ProCT, CT(1-32) and the flanking peptides PAS-57 and PDN-21 were recognised with antibodies specific for the individual peptides. RESULTS ProCT and a 10 kDa polypeptide were recognised with antibodies to PAS-57, CT(1-32) and PDN-21. An 8 kDa proCT fragment was detected with antibodies to CT and PDN-21. However, intact CT(1-32), PAS-57 and PDN-21, found in the serum of MTC patients, were undetectable. The results indicate partial cleavage of proCT in septicaemia different from that in MTC patients. CONCLUSIONS ProCT and 10 and 8 kDa proCT fragments were recognised in the circulation of septic patients. They were different from the known proCT-processing products PAS-57, CT(1-32) and PDN-21 identified in the serum of normal subjects and of MTC patients. Distinct cleavage of proCT may contribute to the symptoms of septicaemia.

[1]  J. Struck,et al.  Isolation and characterization of serum procalcitonin from patients with sepsis , 2001, Peptides.

[2]  Y. Tulzo,et al.  Procalcitonin: a valuable indicator of infection in a medical ICU? , 2000, Intensive Care Medicine.

[3]  M. Meisner,et al.  Procalcitonin as a marker of the systemic inflammatory response to infection , 2000, Intensive Care Medicine.

[4]  C. Bohuon,et al.  Amino‐terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV) , 2000, FEBS letters.

[5]  F. Brunkhorst,et al.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. , 1999, Critical care medicine.

[6]  T. Nishikura.  Procalcitonin (PCT) production in a thyroidectomized patient , 1999, Intensive Care Medicine.

[7]  K. Reinhart,et al.  Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis , 1999, Clinical chemistry and laboratory medicine.

[8]  J. White,et al.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. , 1998, Critical care medicine.

[9]  U. Mittelkötter,et al.  Procalcitonin in Early Detection of Postoperative Complications , 1998, Digestive Surgery.

[10]  K. Becker,et al.  Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[11]  B. Al-Nawas,et al.  Procalcitonin in diagnosis of severe infections. , 1996, European journal of medical research.

[12]  M. Assicot,et al.  High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.

[13]  C. Beglinger,et al.  Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients , 1991, Regulatory Peptides.

[14]  B. Roos,et al.  Biosynthesis of calcitonin gene-related peptide and calcitonin by a human medullary thyroid carcinoma cell line. , 1986, The Journal of biological chemistry.

[15]  J. Ketelslegers,et al.  Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum. , 1985, The Journal of clinical endocrinology and metabolism.

[16]  J. White,et al.  Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. , 2001, The Journal of clinical endocrinology and metabolism.